Lederer & Associates Investment Counsel’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
5,424
+627
+13% +$173K 0.79% 44
2026
Q1
$1.42M Sell
4,797
-54
-1% -$16K 1% 33
2025
Q4
$1.32M Sell
4,851
-105
-2% -$28.5K 0.89% 37
2025
Q3
$1.34M Buy
4,956
+717
+17% +$195K 0.87% 41
2025
Q2
$1.17M Buy
4,239
+110
+3% +$29.9K 0.77% 43
2025
Q1
$1.09M Hold
4,129
0.8% 44
2024
Q4
$959K Buy
+4,129
New +$949K 0.67% 52

Other funds holding CME

Lederer & Associates Investment Counsel's CME Position: Q2 2026 in Review

Lederer & Associates Investment Counsel increased its CME Group (CME) stake by 13% in Q2 2026, buying an estimated $173K and bringing the position to 5,424 shares worth $1.2M. The position accounts for 0.79% of the portfolio, ranked #44.

Lederer & Associates Investment Counsel first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.42M in Q1 2026. 601 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Lederer & Associates Investment Counsel held 5,424 shares of CME Group worth $1.2M as of Q2 2026.
  • Lederer & Associates Investment Counsel bought 627 CME Group shares in Q2 2026, an estimated $173K.
  • CME Group made up 0.79% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #44 holding.
  • Lederer & Associates Investment Counsel first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Lederer & Associates Investment Counsel's CME Group position peaked at $1.42M in Q1 2026.
  • 601 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.